Concord Healthcare Group Co., Ltd. Class H (HK:2453)
:2453
Want to see HK:2453 full AI Analyst Report?
2453 Stock Chart & Stats
HK$1.83
-HK$0.24(-2.76%)
At close: 4:00 PM EST
HK$1.83
-HK$0.24(-2.76%)
Day’s Range― - ―
52-Week RangeHK$0.80 - HK$7.91
Previous CloseN/A
Volume2.50M
Average Volume (3M)590.21K
Market Cap
HK$650.44M
Enterprise ValueHK$3.41B
Total Cash (Recent Filing)HK$319.01M
Total Debt (Recent Filing)HK$3.09B
Price to Earnings (P/E)―
Beta0.41
Next Earnings
Aug 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.34
Shares Outstanding313,874,630
10 Day Avg. Volume440,520
30 Day Avg. Volume590,206
Financial Highlights & Ratios
PEG Ratio0.10
Price to Book (P/B)0.62
Price to Sales (P/S)2.55
P/FCF Ratio-4.39
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue And Gross Margin RecoveryA 21% revenue rebound and a positive gross margin (~7%) in 2025 indicate improving core operations and pricing or cost control. If sustained, this provides a durable pathway to recover operating leverage, fund reinvestment, and narrow losses as scale absorbs fixed costs over months.
Positive And Growing Equity BaseAn increased, positive equity base in 2025 gives a solvency buffer that reduces immediate insolvency risk and supports continuing operations while recovery executes. This structural cushion helps preserve access to financing and limits forced asset sales during a multi‑quarter turnaround.
Proven Cash Generation In Prior YearHistoric positive operating cash flow in 2023 demonstrates the underlying care‑facility model can convert revenue to cash under better operating conditions. That structural capability suggests cash generation can be restored if revenue growth and margins remain on their improving trajectory.
Bears Say
Deep Operating LossesVery large operating and net losses indicate the business is not yet cash‑profitable and must rely on external funding or equity to sustain operations. Persistent deep losses erode retained capital, constrain strategic investments, and raise long‑term viability risks if not reversed.
Weak Cash FlowConsecutive years of negative operating and free cash flow create structural funding pressure, increasing dependence on new debt or equity. This undermines financial flexibility, may necessitate dilutive financing, and limits the firm’s ability to sustainably invest in facilities or quality improvements.
Elevated Leverage And Negative ROEHigh leverage combined with negative returns on equity reduces capacity to absorb shocks and raises interest and covenant risks. Levered losses magnify financing costs and limit strategic options, making the recovery path more fragile and dependent on successful margin restoration.
Concord Healthcare Group Co., Ltd. Class H News
2453 FAQ
What was Concord Healthcare Group Co., Ltd. Class H’s price range in the past 12 months?
Concord Healthcare Group Co., Ltd. Class H lowest stock price was HK$0.80 and its highest was HK$7.91 in the past 12 months.
What is Concord Healthcare Group Co., Ltd. Class H’s market cap?
Concord Healthcare Group Co., Ltd. Class H’s market cap is HK$650.44M.
When is Concord Healthcare Group Co., Ltd. Class H’s upcoming earnings report date?
Concord Healthcare Group Co., Ltd. Class H’s upcoming earnings report date is Aug 27, 2026 which is in 78 days.
How were Concord Healthcare Group Co., Ltd. Class H’s earnings last quarter?
Concord Healthcare Group Co., Ltd. Class H released its earnings results on Mar 26, 2026. The company reported -HK$0.112 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.112.
Is Concord Healthcare Group Co., Ltd. Class H overvalued?
According to Wall Street analysts Concord Healthcare Group Co., Ltd. Class H’s price is currently Overvalued.
Does Concord Healthcare Group Co., Ltd. Class H pay dividends?
Concord Healthcare Group Co., Ltd. Class H does not currently pay dividends.
What is Concord Healthcare Group Co., Ltd. Class H’s EPS estimate?
Concord Healthcare Group Co., Ltd. Class H’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Concord Healthcare Group Co., Ltd. Class H have?
Concord Healthcare Group Co., Ltd. Class H has 313,874,630 shares outstanding.
What happened to Concord Healthcare Group Co., Ltd. Class H’s price movement after its last earnings report?
Concord Healthcare Group Co., Ltd. Class H reported an EPS of -HK$0.112 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -9.167%.
Which hedge fund is a major shareholder of Concord Healthcare Group Co., Ltd. Class H?
Currently, no hedge funds are holding shares in HK:2453
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Concord Healthcare Group Co., Ltd. Class H Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-87.59%
12-Months-Change
Fundamentals
Return on Equity
-15.15%
Trailing 12-Months
Asset Growth
2.55%
Trailing 12-Months
Company Description
Concord Healthcare Group Co., Ltd. Class H
Concord Healthcare Group Co., Ltd. is dedicated to providing comprehensive cancer treatment services for patients and healthcare institutions throughout China. Its operations extend beyond direct care to include the distribution and installation of medical hardware and software, along with offering management and technical assistance, and providing equipment via operating leases. The company was founded in 2008 and is headquartered in Beijing, China. It functions as a subsidiary of Shanghai Medstar Financial Leasing Company.
Technical Analysis
C-MER Eye Care Holdings Limited
―
Hospital Corporation of China Ltd
―
Town Health International Medical Group Ltd.
―
Hygeia Healthcare Holdings Co., Ltd.
―
Arrail Group Ltd.
―